MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.
The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.
Wells
George
G
Department of Clinical Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Anderson
Jennifer
J
Boers
Maarten
M
Felson
David
D
Heiberg
Turid
T
Hewlett
Sarah
S
Johnson
Kent
K
Kirwan
John
J
Lassere
Marissa
M
Robinson
Vivian
V
Shea
Beverley
B
Simon
Lee
L
Strand
Vibeke
V
van Riel
Piet
P
Tugwell
Peter
P
D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D012720:Severity of Illness Index